Sclerodermatous graft versus host disease treated with acetretin

被引：0
|
作者：
Jarrett, P. [1 ]
Chan, W. C. [1 ]
Raj, G. [1 ]
机构：
[1] Middlemore Hosp, Dept Dermatol, Auckland 6, New Zealand
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：A60 / A60
页数：1
相关论文
共 50 条
  • [41] Therapeutic Effects of MLN4924 on Sclerodermatous Chronic Graft Versus Host Disease
    Pai, Chien-Chun Steven
    Chen, Mingyi
    Zamora, Anthony E.
    Khuat, Lam
    Grossenbacher, Steven
    Murphy, William J.
    Abedi, Mehrdad
    BLOOD, 2014, 124 (21)
  • [42] Rituximab as salvage therapy for refractory sclerodermatous chronic graft-versus-host disease
    Namdaroglu, S.
    Iskender, D.
    Dal, M. S.
    Cakar, M. K.
    Tekgunduz, E.
    Altuntas, F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (01): : 12 - 18
  • [43] Lichen sclerosus et atrophicus in sclerodermatous chronic graft-versus-host disease
    Córdoba, S
    Vargas, E
    Fraga, J
    Aragüés, M
    Fernández-Herrera, J
    García-Díez, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (09) : 708 - 711
  • [44] Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease
    Belle, Ludovic
    Fransolet, Gilles
    Somja, Joan
    Binsfeld, Marilene
    Delvenne, Philippe
    Drion, Pierre
    Hannon, Muriel
    Beguin, Yves
    Ehx, Gregory
    Baron, Frederic
    PLoS One, 2016, 11 (12):
  • [45] The effects of mesenchymal stem cells in a murine sclerodermatous model of graft-versus-host disease
    Lim, Ji-Young
    Ryu, Da-Bin
    Lee, Sung-Eun
    Oh, Il-Hoan
    Min, Chang-Ki
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [46] Kinetics of circulating endothelial progenitors in patients with sclerodermatous chronic graft-versus-host disease
    Ahihara, Eishi
    Shimura, Kazuho
    Shimazaki, Chihiro
    Matsunaga, Shinsaku
    Tanaka, Ruriko
    Yokota, Asumi
    Murotani, Yoshihide
    Takeuchi, Miki
    Kawata, Eri
    Kamitsuji, Yuri
    Kuroda, Junya
    Taniwaki, Masafumi
    Kimura, Shinya
    Maekawa, Taira
    BLOOD, 2007, 110 (11) : 326A - 327A
  • [47] Sclerodermatous chronic graft-versus-host disease induced by host T-cell-mediated autoimmunity
    Lee, You Jeong
    Min, Hye Sook
    Kang, Eun Ha
    Park, Hyo Jin
    Jeon, Yoon Kyung
    Kim, Ju Hyun
    Wu, Hong Gyun
    Lee, Eun-Bong
    Park, Chung-Gyu
    Yoon, Sung-Soo
    Park, Seong Hoe
    Jung, Kyeong Cheon
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (03): : 358 - 367
  • [48] Blockade of Syk Ameliorates the Development of Sclerodermatous Chronic Graft-Versus-Host Disease.
    Matsushita, T.
    Le Huu, D.
    Kimura, H.
    Date, M.
    Hamaguchi, Y.
    Hasegawa, M.
    Fujimoto, M.
    Takehara, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S3 - S3
  • [49] Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions
    Phipps, C.
    Lupo-Stanghellini, M. T.
    Flowers, M. E. D.
    BONE MARROW TRANSPLANTATION, 2014, 49 (02) : 315 - 316
  • [50] Etretinate: A novel agent for the treatment of refractory sclerodermatous chronic graft versus host disease.
    Marcellus, DC
    Altomonte, V
    Farmer, ER
    Horn, TD
    Freemer, C
    Grant, J
    Vogelsang, GB
    BLOOD, 1995, 86 (10) : 1579 - 1579
12345